Rofecoxib interaction with oral anticoagulant acenocoumarol.
Girardin
François
F
Siegenthaler
Michèle
M
De Moerloose
Philippe
P
Desmeules
Jules
J
D000074:Acenocoumarol / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D001682:Biological Availability; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D007783:Lactones / Q000494:pharmacology* / Q000627:therapeutic use; D013450:Sulfones; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D000074:Acenocoumarol